Levocetirizine dihydrochloride is a third-generation non-sedating antihistamine drug derived from the second generation anti-histamine cetrizine. It is H1receptorantagonist.Allergic rhinitis is a symptomatic disorder of the nose induced by inflammation mediated by immunoglobulinE (IgE) in the membrane lining the nose after allergen exposure. Thus, formulating Levocetirizine into an orodispersible dosage form would provide fast relief. The Levocetirizine is bitter in taste so the Kyron T-134 (ion exchange resin synthetic which is inert organic polymers consist of hydrocarbon network to which ionizable groups are attached and they have the ability to exchange their labile ions for ions present in the solution with which they are in contact) was used to mask the taste and to formulate Mouth dissolving tablets using drug resin complex. The tablets were evaluated for the drug content, weight variation, water absorption ratio, wetting time, invitro disintegration, hardness, friability, thickness. All the parameters were found to be acceptable in range. The optimized formulation was disintegrated in 25 seconds and complete drug was released from tablet in10 minutes. It has been compared with marketed formulation and the drug release rate was found to be enhanced. Thus, results showed that Levocetirizine dihydrochloride was successfully formulated into Mouth Dissolving Tablets.
INTRODUCTION
Oral route is always the favored route for administration of drugs due to accurate dosage, self-medication, low cost and ease of administration which leads to elevated patient compliance [1] . Solid dosage forms also present considerable administration challenges in children, mentally challenged and uncooperative patients. So, to accomplish the requirements of patients' recent advancements in technology have resulted in development of viable dosage form namely orally disintegrating tablets (ODTs) which disintegrates tablet in mouth without water in few seconds. The MDT formulation is defined by the food and drug administration (FDA) as "A solid dosage form which disintegrates rapidly when sited on the tongue thus realizing and dissolving the active ingredient and allowing absorption through all possible membranes [2] .
A wide no. of taste buds is there in our mouth (roof of the tongue, mouth, cheeks and throat). Each bud has 60-100 receptor cells. These cells interact with molecules in saliva and produce a positive/negative sensation. Each taste bud has a pore that opens out to surface of the tongue enabling molecules and ions to reach the receptor cells inside [3] . Ion exchange resins have been increasingly used for the taste masking of bitter taste drugs. Ion exchange resins are synthetic inert organic polymers consist of hydrocarbon network to which ionizable groups are attached and they have the ability to exchange their labile ions for ions present in the solution with which they are in contact. Levocetrizine dihydrochloride is an orally active and R-enantiomer of cetrizine and is a third generation, nonsedating selective peripheral H1-receptor antagonist used in seasonal allergic rhinitis, perennial allergic rhinitis, and chronic urticaria [4] .
Preparation of Drug Resin Complex by Batch Method
In this method the drug solution is agitated with a quantity of resin particles until equilibrium is established [6] . The resins were first washed with distilled Water till neutralization. 300 mg of resin was placed in a beaker containing 25 ml of deionised water and allowed to swell for 90 min. The pH of the resin solution was adjusted to 6.5 to 7.0 by using 1 M KOH solution than accurately weighed 100 mg of Levocetirizine dihydrochloride was added to the resin solution and stirred for 2-3 hours. During stirring, pH of the sample was checked frequently and adjusted to 6.5 to 7.0 by using 1 M KOH solution. Than the mixture was filtered through Whatman filter paper no. 41 and residue was washed with 75 ml of deionised water and put it for drying at 60 0 C for 3-4 hours in oven.
Formulation of Mouth Dissolving Tablets by Direct Compression
Crosspovidone and SSG were selected as super disintegrates. Flavours, talc (glidant), magnesium Stearate (lubricant), Mannitol & microcrystalline cellulose were selected [6] . Superdisintegrants have excellent disintegrating ability to swell to a large extent when it come in contact with water to disintegrate and has a fibrous nature that allow intraparticulate as well as extra particulate wicking of water even at low concentration. Firstly, the DRC consist of drug-resin complex 20 mg was prepared. The DRC and other Excipients were transferred in RMG (rapid mix granulator) mixer and was mixed for 10 minutes (dry mix) purified water was added if required and for approx. 30 minutes was mixed (wet mix) granules were formed [7] . The wet granules were passed through multimill which was fitted with sieve no.10 and then the wet granules were collected in FBD (fluidized bed dryer) and dried for 5 minutes at temperature of 60 o C. The dried granules passed through sieve no. 40 and sizing was done through cad mill using screen of 1.0 mm at slow speed. All the ingredients were passed through sieve no. 40 and blending was performed through rotacube mixer. All the five batches were prepared by direct compression method using single punch machine [8] . The hardness of the tablet of each batch were tried to keep constant (2.4kg/cm 2 ). The weight of the tablet of each batch was adjusted to 135 mg.
The tablet was evaluated for its weight variation, friability, disintegration time. Dissolution study of tablets was carried out in simulated gastric fluid [9] .
The trials taken in preparing formulation are shown in Table 1 . 
Formulation & optimization of drug resin complex
Drug resin concentration 1:3 ratio showed maximum drug loading (Table 2) . If further increase the resin concentration (1:4) leads to the saturation of complex formation therefore resin ratio (1:3) was selected as optimized batch.
Drug resin ratio 1:3 showed maximum drug loading at 60 minutes. If further increase the time, did not increase the loading efficiency therefore it was selected as optimized formulation as given in Table 3 , Fig. 1 . Drug resin ratio 1:3 showed maximum drug loading at pH 4. It was observed that the drug resin ratio 1:3 have maximum ionization and solubility at pH 4 that's why pH 4 was selected as optimized pH as shown in Table 4 . 
Evaluation of various parameters
Among all the formulations batch F4 showed least disintegration time and wetting time and maximum water absorption ratio therefore batch F4 was selected as optimized batch Table 5 . 
General Appearance
Tablets showed flat, circular shape after direct compression and white in color.
Thickness Test
The thickness of the tablet was measured by using vernier calliper by picking the tablets randomly. Thickness was found in the range from 2.9±0.00mmto 2.9± 0.04 mm respectively. Uniformity in the values indicates that formulations were compressed without sticking to the dies and punches.
Hardness Test
Hardness test was performed by Monsanto Hardness tester. Hardness was found within2.4kg/cm2 to2.9kg/cm2, as the tablets are orodispersible. The lower standard deviation values indicated that the hardness of all the formulations were almost uniform and possess good mechanical strength with sufficient hardness. The result of hardness for all the formulations are given in and the hardness of the optimized formulation (F4) was found to be 2.4 ± 0.178.
Friability Test
Percentage friability was found well within the approved range (<1%) in all the formulation. Results revealed that the tablets possess good mechanical strength. The result of friability for all the formulations aregiveninTable7and the friability of the optimized formulation (F4) was found to be 0.18 ± 0.732. Int. J. Res. Dev. Pharm. L. Sci. 3107
Weight Variation Test
All the tablets passed weight variation test as the % weight variation was within the pharmacopeia limits of ±7.5%.
Drug Content Uniformity
Three trials from each formulation were analyzed spectrophotometrically. The mean value and standard deviation of all the formulations was calculated. The % drug content for all the formulations were found between 89.94 ± 0.85 to 98.97 ± 0.76. The % drug content of the optimized formulation (F4) was found to be 98.97 ± 0.76.
Wetting Time
The wetting time in all the formulations was very fast. This may be due to ability of swelling and also capacity of absorption of water. SSG absorbs water rapidly in the formulations and shows fast wetting time. This parameter also duplicates disintegration time in oral cavity as tablet is kept motion less on tongue; hencecorrelationbetweenwettingtimeanddisintegrationtimeinoral cavitycanalso be made. The wetting time of the optimized formulation (F4) was found to be 20 ± 0.413.
Water Absorption Ratio
The ratio values of formulations found in the range of 75.10 ± 0.31 to 87.12 ± 0.76. In case of tablet containing SSG, caused great deal of swelling. In this as the quantity of SSG increased the water absorption so increased due to high swelling property. The water absorption ratio results for all the formulations are given in Table7and the water absorption ratio of the optimized formulation (F4) was found to be 87.12 ± 0.76.
In vitro Disintegration Time
All formulations showed disintegration time within 42 seconds. The DT decreases with increase in the level of SSG 2, 2.5, 3, 3.5, 4 % and Crosspovidone 3.5, 4, 4.5, 5, 5.5 % in the tablets but at concentration 4 and 5.5 DT of batch F5 decreases. Because at a higher level, formation of a viscous gel layer by SSG might have formed a thick barrier to the further penetration of the disintegration medium and hindered the disintegration or leakage of tablet contents.
It indicates that increase in the level of SSG had negative effect on the DT of tablets. Thus, tablets containing more than 4% SSG may be retarded the DT time. The results of disintegration time for all the formulations and the disintegration time of the optimized formulation (F4) was found to be 25 ± 0.765 Table 6 , Fig. 2 . The time intensity study for taste in human volunteers of the drug, DRC showed that the degree of bitterness ultimately reaching to +0 within 3 minutes which showed the palatability of the formulation concluding that the bitter taste of formulation has been successfully masked Table 7 .
As the concentration of superdisintegrants increases the disintegration time decreases but at concentration 5.5 (crosspovidone) and 4(SSG) DT of batch F5 decreases Because at a higher level, formation of a viscous gel layer by SSG might have formed a thick barrier to the further penetration of the disintegration medium and hindered the disintegration or leakage of tablet contents. It indicates that increase in the level of SSG had negative effect on the DT of tablets Table 8 . 
Stability studies
The stability studies of optimized formulation were carried out and it was concluded from the results that the formulation F4 was stable for 60 days Table 9 . Fig. 4 .
SUMMARY
A recent advance in Novel Drug Delivery System aims to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance. One such approach is Orodispersible Tablet. Drug loading percentage of Levocetrizine dihydrochloride was established by using deionised water and was found to be 92.12%.
Effect of swelling time was determined in sample containing drug: resin ratio of 1:3, it was found that the drug loading percentage was highest at 120min i.e. 95.22%. Maximum drug loading 0f 98% was obtained at pH 6.5.
The Orodispersible tablets were formulated by direct compression method using different superdisintegrants namely Sodium starch Glycolate, Crosspovidone.
Prepared tablets were evaluated for shape, harness, thickness, friability, uniformity of weight, uniformity of content, wetting time, water absorption ration, disintegration time and in-vitro drug release. 
